OTUD6B and glioblastoma: In addition, our results showed that a high OTUD6B level was significantly correlated with poor PFI in patients with UVM, GBM, SKCM, LIHC, KICH, LUAD, and LGG, while a low OTUD6B expression was correlated with better PFI in patients with KIRC (Figure 5D).